We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-2.71%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.72B
AUM Growth
+$155M
Cap. Flow
+$383M
Cap. Flow %
14.1%
Top 10 Hldgs %
44.97%
Holding
397
New
176
Increased
47
Reduced
34
Closed
47

Top Buys

Rank Stock Value
1
OPEN icon
Opendoor
OPEN
+$101M
2
PPLI
People Inc
PPLI
+$62.3M
3
CNDA
Concord Acquisition Corp II
CNDA
+$24.3M
4
HLF icon
Herbalife
HLF
+$23.6M
5
RGTI icon
Rigetti Computing
RGTI
+$23M

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$32.6M
2
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
+$29.9M
3
CNDA.U
Concord Acquisition Corp II Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
CNDA.U
+$24.7M
4
CND
Concord Acquisition Corp.
CND
+$21.3M
5
TPGS
TPG Pace Solutions Corp.
TPGS
+$19.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Healthcare 13.28%
3 Consumer Discretionary 9.47%
4 Communication Services 8.32%
5 Real Estate 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OACB
76
DELISTED
Oaktree Acquisition Corp. II
OACB
$7.41M 0.27%
+750,000
New +$7.41M
CMBT
77
CMB.TECH NV
CMBT
$4.62B
$7M 0.26%
787,000
+150,000
+24% +$1.46M
HWKZ.U
78
DELISTED
Hawks Acquisition Corp Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant
HWKZ.U
$6.91M 0.25%
+700,000
New +$6.95M
TRTN
79
DELISTED
Triton International Limited
TRTN
$6.63M 0.24%
+110,000
New +$6.41M
IRCP
80
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$5.87M 0.22%
2,594,814
– –
EUCR
81
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$5.86M 0.22%
600,000
– –
VCSA
82
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$5.84M 0.21%
+35,082
New +$5.68M
MLTX icon
83
MoonLake Immunotherapeutics
MLTX
$1.53B
$5.84M 0.21%
590,000
+440,000
+293% +$4.37M
PHAT icon
84
Phathom Pharmaceuticals
PHAT
$684M
$5.72M 0.21%
+290,595
New +$6.84M
M icon
85
PUT
Macy's
M
$6.89B
$5.24M 0.19%
+200,000
New +$5.45M
OHAAU
86
DELISTED
OPY Acquisition Corp. I Units
OHAAU
$5M 0.18%
+500,000
New +$4.99M
GTAC
87
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$4.96M 0.18%
+505,000
New +$4.94M
ARGU
88
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
$4.95M 0.18%
+500,000
New +$4.95M
NKGN
89
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$4.84M 0.18%
500,000
– –
GIW
90
DELISTED
GigInternational1, Inc. Common Stock
GIW
$4.77M 0.18%
480,000
– –
DEO icon
91
Diageo
DEO
$48.8B
$4.75M 0.17%
21,600
-6,000
-22% -$1.23M
GCTS
92
GCT Semiconductor Holding
GCTS
$203M
$4.7M 0.17%
+475,000
New +$4.68M
IVVD icon
93
Invivyd
IVVD
$169M
$4.5M 0.17%
+620,000
New +$16.1M
VTIQ
94
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$4.42M 0.16%
454,001
+4
+0% +$39
GMFIU
95
DELISTED
Aetherium Acquisition Corp Unit
GMFIU
$4M 0.15%
+400,000
New +$4M
TYGO icon
96
Tigo Energy
TYGO
$155M
$3.96M 0.15%
400,000
+10,000
+3% +$98.8K
PAQC
97
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
$3.94M 0.14%
400,002
+1
+0% +$10
DNZ
98
DELISTED
D and Z Media Acquisition Corp.
DNZ
$3.9M 0.14%
400,000
+100,000
+33% +$975K
CBAY
99
DELISTED
Cymabay Therapeutics
CBAY
$3.72M 0.14%
+1,100,000
New +$4.18M
ENER
100
DELISTED
Accretion Acquisition Corp
ENER
$3.66M 0.13%
+375,000
New +$3.66M
2 3
4
5 6

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, 683 Capital Management held 397 positions worth $2.72B, up 6% from $2.56B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management deployed $383M of net new capital in Q4 2021, opening 176 new positions and adding to 47 existing holdings. Its largest new stake was Concord Acquisition Corp II: 2,475,000 shares worth $24.1M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was PG&E, an estimated $32.6M trimmed.

  • 683 Capital Management's largest Q4 2021 buy was Concord Acquisition Corp II: 2,475,000 shares worth $24.1M.
  • 683 Capital Management added most to Opendoor in Q4 2021, an estimated $101M increase.
  • 683 Capital Management's biggest Q4 2021 reduction was PG&E, cutting an estimated $32.6M.
  • 683 Capital Management fully exited SmileDirectClub, Inc. Class A Common Stock in Q4 2021, selling an estimated $29.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $2.72B portfolio in Q4 2021.
  • 683 Capital Management opened 176 new positions and closed 47 in Q4 2021.
  • 683 Capital Management's portfolio value rose 6% quarter-over-quarter to $2.72B.

Based on 683 Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.